Summary of MedTech M&A In 2022: Is It Still A Sellers' Market?

00:00:00 - 00:50:00

The video discusses the current state of the medtech market and provides advice for companies interested in joining the market. It highlights that the market is still a sellers' market, with buyers looking for companies that are a good fit for their portfolio. The biggest impacts on the medtech industry in the next few years will be the wars in Europe and Asia.

• 00:00:00 The presenters discuss the current medtech market, and whether or not it is still a sellers' market. They give examples of companies with a history of success in the medtech industry, and offer advice to those interested in joining the market.
• 00:05:00 The author of the video discusses the current state of the medical technology market, which is still a sellers' market. They discuss the various attributes that make a company a good candidate for sale and how to navigate the market to find the right buyer.
• 00:10:00 In 2022, the market for medtech acquisitions is still a sellers' market, as companies face increasing regulatory burdens. However, smaller players are looking to exit the market, and some larger companies are refreshing their product lines.
• 00:15:00 In 2022, the market for medical technology and healthcare deals was record-breaking. This was due to a number of factors, including the creation of specs, the increase in foreign investment, and the decline of healthcare venture capital. This has created opportunities for companies that were already in the market, as well as new entrants.
• 00:20:00 The video discusses how the capital investment in healthcare has decreased in the past year, specifically due to the global political events of Brexit and the war in Europe. Despite this, buyers are still active and interested in acquiring healthcare companies.
• 00:25:00 In 2022, the market for medical technology acquisitions is still a sellers' market, though transaction value and number of deals have increased. Foreign investment is still driving the market, though private equity and venture capital are getting more involved.
• 00:30:00 In 2022, the Middle Market for Medtech will remain competitive, with Financial buyers looking for companies with high EBITDA. However, there will be more competition for deals, as Strategic buyers look for companies with a higher equity value and potential for growth.
• 00:35:00 In 2022, the market for medical technology will remain a buyers' market, as companies look to add medical or med tech into their portfolios. The most in-demand medical tech sectors will be robotic surgery and home care, with orthopedic implants and healthcare staffing also being important.
• 00:40:00 The video discusses the challenges faced by hospitals in transitioning to value-based care, and how this has made it more difficult for companies to be acquired. It also mentions the growth of India, China, and Japan as markets that are still ripe for acquisition.
• 00:45:00 In 2022, the market for medtech M&A was still a sellers' market, with companies looking to either sell or partner with other, more experienced, companies. However, in 2023, the market has stabilized and is now more similar to 2022, with companies looking to claim their market share. The biggest impacts on the medtech industry in 2022 and 2023 were the wars in Europe and Asia, respectively. Japan is still very aggressive in its investment in medtech, while China is more internally focused for the moment. Taiwan is in the middle of all of this, but is still creating opportunities for medtech companies around the world.
• 00:50:00 The speaker provides insights on the current state of the Medtech industry, highlighting that it is still a sellers' market. They provide contact information for Dave and Florence, who are experts on the subject. Attendees are encouraged to watch the recording of the webinar for further insights.